市場調査レポート

商品コード

1660681

生検装置市場レポート：手技タイプ、製品、用途、ガイダンス技術、エンドユーザー、地域別、2025年～2033年

Biopsy Devices Market Report by Procedure Type, Product, Application, Guidance Technique, End User, and Region 2025-2033

出版日: 2025年02月10日
発行: IMARC
ページ情報: 英文 141 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF & Excel (Single User License)

USD 2,999 440,313円

レポートPDFおよびExcelを1名のみがご利用頂けるライセンスです。PDFおよびExcelの印刷は一度のみ可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (5 User License)

USD 3,999 587,133円

レポートPDFおよびExcelを同一企業内の5名様までがご利用頂けるライセンスです。PDFおよびExcelの印刷は可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Corporate License)

USD 4,999 733,953円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等の編集は可能ですが、事前にIMARC Services Private Limited社の許可が必要です。PDFおよびExcelの印刷回数に制限はありません。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.82円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

生検装置の世界市場規模は2024年に28億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに46億米ドルに達し、2025年から2033年にかけて5.47%の成長率（CAGR）を示すと予測しています。がん罹患率の上昇、個別化医療への嗜好の高まり、患者の快適性と回復時間の短縮を目的とした低侵襲手技の推進は、市場を推進する主な要因の一部です。

生検装置は、診断目的で患者の体内から組織サンプルを採取するために特別に設計された医療器具です。様々なヘルスケア現場で広く使用されており、がん、感染症、炎症性疾患など幅広い疾患の診断に役立っています。針生検装置、鉗子生検装置、真空アシスト生検装置などさまざまなタイプがあり、それぞれが特定の医療ニーズに対応しています。超音波、CTスキャン、MRIのようなリアルタイムの画像診断技術を用いることで、ヘルスケア専門家は組織を採取する必要がある場所を正確に特定することができ、手技の成功率を向上させることができます。その結果、生検装置は現代の診断医療に不可欠なツールとして絶大な支持を集め、正確でタイムリーな介入を容易にしています。

診断に生検を必要とする疾患に罹患しやすい高齢化社会は、予測期間中の市場成長を刺激するであろう。加えて、個別化医療への注目の高まりは、疾患の進行をモニターし、それに応じて治療計画を適応させるために、しばしば複数回の生検を必要とするため、生検装置の使用頻度を増加させる。これに伴い、患者の快適性と回復時間の短縮を目的とした低侵襲手技の世界の推進により、これらの低侵襲手技用に設計された生検装置の採用が加速しています。さらに、いくつかの国々におけるヘルスケア支出の増加と支援的な償還政策が市場成長に寄与しています。世界中の政府や民間保険会社がより良いヘルスケアサービスの提供を目指しているため、生検のような診断手技に対する償還の可能性が高くなり、患者にとってより利用しやすいものとなって市場成長を後押ししています。

生検装置市場動向/促進要因：

がん罹患率の上昇

世界のがん罹患率の増加は、生検装置市場の重要なドライバーです。がんの診断には、最適な治療のために正確かつ早期の同定が必要であり、生検は不可欠な診断ツールとなっています。世界保健機関（WHO）によると、がんは世界第2位の死因であり、2018年には推定960万人が死亡しています。がんの発生率が上昇を続ける中、正確で効率的な診断方法の必要性が高まっています。そのため、生検装置は悪性組織の特定に不可欠なものとなりつつあり、臨床医が適切な治療計画を立てることができるようになっています。がん罹患率の上昇は、高度な生検装置の需要を喚起し、市場成長にプラスの影響を与えています。

急速な技術進歩

生検装置の技術革新は、もう一つの大きな成長促進要因です。技術の進歩は生検手技の有効性、スピード、安全性を向上させています。例えば、真空アシスト生検装置は、より迅速で快適な組織サンプルの抽出を可能にし、それによって患者の経験を向上させています。さらに、超音波、CTスキャン、MRIなどのリアルタイム画像診断技術を生検装置に統合することで、医師はより正確な標的部位を得ることができ、手技の合併症を減らし、診断の信頼性を高めることができます。このような技術的強化は、ヘルスケア専門家による製品採用率の向上に寄与し、ひいては市場の成長を後押ししています。

ヘルスケア・インフラへの大規模投資

新興国を中心にヘルスケアインフラへの投資が増加していることも、市場の成長を後押ししています。公的機関や民間機関による資金提供の増加は、診断ラボや最先端の医療機器の購入を含む医療施設の近代化を促進しています。ヘルスケアシステムが世界的に、より正確でタイムリーな診断を提供することに注力しているため、高度な生検装置の導入は自然な流れとなっています。このことは、患者にとって質の高い診断手技への幅広いアクセスを確保する一方で、これらの機器の市場を拡大し、市場成長にプラスの推進力をもたらしています。

北米
- 米国
- カナダ
アジア太平洋地域
- 中国
- 日本
- インド
- 韓国
- オーストラリア
- インドネシア
- その他
欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- ロシア
- その他
ラテンアメリカ
- ブラジル
- メキシコ
- その他
中東・アフリカ
- 市場動向
- 市場内訳：国別
- 市場予測

第12章 SWOT分析

概要
強み
弱み
機会
脅威

第13章バリューチェーン分析

第14章ポーターのファイブフォース分析

概要
買い手の交渉力
供給企業の交渉力
競合の程度
新規参入業者の脅威
代替品の脅威

第15章価格指標

第16章競合情勢

市場構造
主要企業
主要企業のプロファイル
- Argon Medical Devices
- Becton Dickinson and Company
- Boston Scientific Corporation
- Cardinal Health Inc.
- CONMED Corporation
- Cook Group Incorporated
- Hologic Inc.
- INRAD Inc.
- Medtronic plc

図表

List of Figures

Figure 1: Global: Biopsy Devices Market: Major Drivers and Challenges
Figure 2: Global: Biopsy Devices Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Biopsy Devices Market: Breakup by Procedure Type (in %), 2024
Figure 4: Global: Biopsy Devices Market: Breakup by Product (in %), 2024
Figure 5: Global: Biopsy Devices Market: Breakup by Application (in %), 2024
Figure 6: Global: Biopsy Devices Market: Breakup by Guidance Technique (in %), 2024
Figure 7: Global: Biopsy Devices Market: Breakup by End-User (in %), 2024
Figure 8: Global: Biopsy Devices Market: Breakup by Region (in %), 2024
Figure 9: Global: Biopsy Devices Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 10: Global: Biopsy Devices (Surgical Biopsy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Biopsy Devices (Surgical Biopsy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Biopsy Devices (Needle Biopsy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Biopsy Devices (Needle Biopsy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Biopsy Devices (Biopsy Guidance Systems) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Biopsy Devices (Biopsy Guidance Systems) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Biopsy Devices (Needle Based Biopsy Guns) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Biopsy Devices (Needle Based Biopsy Guns) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Biopsy Devices (Biopsy Needles) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Biopsy Devices (Biopsy Needles) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Biopsy Devices (Biopsy Forceps) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Biopsy Devices (Biopsy Forceps) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Biopsy Devices (Others) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Biopsy Devices (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Biopsy Devices (Breast Biopsy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Biopsy Devices (Breast Biopsy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: Global: Biopsy Devices (Lung Biopsy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: Global: Biopsy Devices (Lung Biopsy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: Global: Biopsy Devices (Colorectal Biopsy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: Global: Biopsy Devices (Colorectal Biopsy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: Global: Biopsy Devices (Prostate Biopsy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: Global: Biopsy Devices (Prostate Biopsy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: Global: Biopsy Devices (Others) Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: Global: Biopsy Devices (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: Global: Biopsy Devices (Ultrasound-guided Biopsy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: Global: Biopsy Devices (Ultrasound-guided Biopsy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: Global: Biopsy Devices (Stereotactic-guided Biopsy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: Global: Biopsy Devices (Stereotactic-guided Biopsy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: Global: Biopsy Devices (MRI-guided Biopsy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: Global: Biopsy Devices (MRI-guided Biopsy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: Global: Biopsy Devices (Others) Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: Global: Biopsy Devices (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: Global: Biopsy Devices (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: Global: Biopsy Devices (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: Global: Biopsy Devices (Academic and Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: Global: Biopsy Devices (Academic and Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: Global: Biopsy Devices (Others) Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: Global: Biopsy Devices (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: North America: Biopsy Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: North America: Biopsy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: United States: Biopsy Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: United States: Biopsy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: Canada: Biopsy Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: Canada: Biopsy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: Asia Pacific: Biopsy Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: Asia Pacific: Biopsy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: China: Biopsy Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: China: Biopsy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: Japan: Biopsy Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: Japan: Biopsy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: India: Biopsy Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: India: Biopsy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: South Korea: Biopsy Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: South Korea: Biopsy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: Australia: Biopsy Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: Australia: Biopsy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: Indonesia: Biopsy Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: Indonesia: Biopsy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: Others: Biopsy Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: Others: Biopsy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: Europe: Biopsy Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: Europe: Biopsy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: Germany: Biopsy Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: Germany: Biopsy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 74: France: Biopsy Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 75: France: Biopsy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 76: United Kingdom: Biopsy Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 77: United Kingdom: Biopsy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 78: Italy: Biopsy Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 79: Italy: Biopsy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 80: Spain: Biopsy Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 81: Spain: Biopsy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 82: Russia: Biopsy Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 83: Russia: Biopsy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 84: Others: Biopsy Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 85: Others: Biopsy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 86: Latin America: Biopsy Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 87: Latin America: Biopsy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 88: Brazil: Biopsy Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 89: Brazil: Biopsy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 90: Mexico: Biopsy Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 91: Mexico: Biopsy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 92: Others: Biopsy Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 93: Others: Biopsy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 94: Middle East and Africa: Biopsy Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 95: Middle East and Africa: Biopsy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 96: Global: Biopsy Devices Industry: SWOT Analysis
Figure 97: Global: Biopsy Devices Industry: Value Chain Analysis
Figure 98: Global: Biopsy Devices Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Biopsy Devices Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Biopsy Devices Market Forecast: Breakup by Procedure Type (in Million USD), 2025-2033
Table 3: Global: Biopsy Devices Market Forecast: Breakup by Product (in Million USD), 2025-2033
Table 4: Global: Biopsy Devices Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 5: Global: Biopsy Devices Market Forecast: Breakup by Guidance Technique (in Million USD), 2025-2033
Table 6: Global: Biopsy Devices Market Forecast: Breakup by End-User (in Million USD), 2025-2033
Table 7: Global: Biopsy Devices Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 8: Global: Biopsy Devices Market: Competitive Structure
Table 9: Global: Biopsy Devices Market: Key Players

Product Code: SR112025A1965

The global biopsy devices market size reached USD 2.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.6 Billion by 2033, exhibiting a growth rate (CAGR) of 5.47% during 2025-2033. The rising prevalence of cancer, increasing preference for personalized medicine, and the push toward minimally invasive procedures for patient comfort and quicker recovery times are some of the major factors propelling the market.

Biopsy devices are medical instruments specifically designed for extracting tissue samples from a patient's body for diagnostic purposes. They are widely used in various healthcare settings and are instrumental in diagnosing a wide range of conditions, including cancer, infections, and inflammatory diseases. They are available in different types, such as needle, forceps, and vacuum-assisted biopsy devices, each serving particular medical requirements. By employing real-time imaging techniques like ultrasound, CT scans, or MRI, healthcare professionals can pinpoint the exact location from which the tissue needs to be taken, thereby improving the procedure's success rate. As a result, biopsy devices have gained immense traction as indispensable tools in modern diagnostic medicine, facilitating precise and timely interventions.

The aging population, which is more susceptible to diseases requiring biopsy for diagnosis, will stimulate market growth during the forecast period. Additionally, the heightened focus on personalized medicine, which often necessitates multiple biopsy procedures to monitor the disease's progression and adapt the treatment plan accordingly, increases the frequency of biopsy device usage. In line with this, the global push toward minimally invasive procedures for patient comfort and quicker recovery times has accelerated the adoption of biopsy devices designed for these less intrusive techniques. Furthermore, the rising healthcare expenditure and supportive reimbursement policies in several countries are contributing to market growth. As governments and private insurers across the globe aim to provide better healthcare services, there is a higher likelihood of reimbursements for diagnostic procedures like biopsies, making them more accessible to patients fueling the market growth.

Biopsy Devices Market Trends/Drivers:

Rising Incidence of Cancer

The increasing burden of cancer worldwide is a significant driver for the biopsy devices market. Cancer diagnoses require precise and early-stage identification for optimal treatment, making biopsies an essential diagnostic tool. According to the World Health Organization, cancer is the second leading cause of death globally, responsible for an estimated 9.6 million deaths in 2018. As cancer rates continue to escalate, there has been a rise in the need for accurate and efficient diagnostic methods. Therefore, biopsy devices are becoming vital in identifying malignant tissues, allowing clinicians to formulate appropriate treatment plans. The rising incidence of cancer catalyzes the demand for advanced biopsy devices, thus positively influencing market growth.

Rapid Technological Advancements

Innovations in biopsy devices represent another major growth-inducing factor. Technological advancements are improving the efficacy, speed, and safety of biopsy procedures. For instance, vacuum-assisted biopsy devices allow quicker and more comfortable extraction of tissue samples, thereby enhancing patient experience. Additionally, the integration of real-time imaging techniques such as ultrasound, CT scans, or MRI with biopsy devices provides physicians with a more accurate target area, reducing procedural complications and increasing diagnostic reliability. Such technological enhancements contribute to higher product adoption rates among healthcare professionals, which in turn is propelling market growth.

Extensive Investments in Healthcare Infrastructure

The rising investments in healthcare infrastructure, especially in emerging economies, also drive the market toward growth. The increased funding by public and private agencies facilitates the modernization of medical facilities, including diagnostic labs and the acquisition of state-of-the-art medical equipment. As healthcare systems globally are focusing on delivering more accurate and timely diagnostics, the incorporation of advanced biopsy devices becomes a natural progression. This has expanded the market for these devices while ensuring broader access to high-quality diagnostic procedures for patients, thus providing a positive thrust to the market growth.

Biopsy Devices Industry Segmentation:

Breakup by Procedure Type:

Surgical Biopsy
Needle Biopsy

Surgical biopsy dominates the market

Surgical biopsy is widely preferred among healthcare professionals for accurate and comprehensive tissue analysis due to its high diagnostic accuracy and versatility. Unlike other biopsy methods, such as needle or liquid biopsies, surgical biopsies enable the removal of an entire tumor or a larger section of tissue, providing a more comprehensive sample for analysis. This increased sample size enhances the ability of pathologists to make accurate and definitive diagnoses, particularly in complex cases where malignancy is suspected but not confirmed through less invasive methods. Additionally, surgical biopsies are often employed in locations difficult to access by needle-based techniques, such as deeper tissues or organs. Another major contributing aspect is its utility beyond diagnosis; it often serves as both a diagnostic and therapeutic procedure by allowing for the complete excision of small malignant masses. The surgical approach is also favored in cases requiring immediate intervention or when other biopsy methods have yielded inconclusive results, thus supporting the segment growth.

Breakup by Product:

Biopsy Guidance Systems
Needle Based Biopsy Guns
Biopsy Needles
Biopsy Forceps
Others

Biopsy guidance systems represent the most popular product

Biopsy guidance systems are crucial in enhancing the accuracy and efficiency of biopsy procedures. These guidance systems often integrate with imaging technologies like ultrasound, MRI, or CT scans to provide real-time visualization of the tissue area being targeted. Such integration allows healthcare professionals to precisely locate and assess the tissue sample needed for diagnosis, thereby reducing the risk of complications and procedural errors. In a medical landscape where precision is paramount, these guidance systems offer a significant edge. Their utility is especially prominent in complex cases where the targeted tissue is located deep within the body or near critical organs, where pinpoint accuracy is essential. Moreover, guidance systems are becoming increasingly user-friendly and compatible with various types of biopsy devices, which promotes their adoption across different healthcare settings. By facilitating quicker, more accurate, and safer procedures, biopsy guidance systems are indispensable tools that clinicians rely on, which is fueling the segment growth.

Breakup by Application:

Breast Biopsy
Lung Biopsy
Colorectal Biopsy
Prostate Biopsy
Others

Breast biopsy accounts for the majority of the market share

The main factor driving the growth of this segment is the high incidence of breast cancer globally. According to the World Cancer Research Fund, breast cancer is the most commonly occurring cancer in women and the second most common cancer overall. Early detection is critical for effective treatment, and biopsy remains one of the most reliable diagnostic methods for confirming the presence or absence of cancerous cells in breast tissue. Furthermore, advances in imaging technologies such as mammography and ultrasound have significantly improved the accuracy of breast biopsies, making it a preferred diagnostic option. Public awareness campaigns about the importance of early detection have also played a role in the frequent utilization of breast biopsy procedures. Increasingly, women are becoming proactive about their breast health, leading to more screenings and, subsequently, more biopsies to confirm or rule out malignancy. As a result, the breast biopsy segment continues to maintain its leading position in the biopsy devices market.

Breakup by Guidance Technique:

Ultrasound Guided Biopsy
Stereotactic Guided Biopsy
MRI Guided Biopsy
Others

Ultrasound guided biopsy holds the largest share in the market

Ultrasound-guided biopsy provides real-time imaging, allowing healthcare professionals to visualize the exact area from which the tissue sample is to be extracted. This enhances the accuracy and efficiency of the biopsy procedure. Moreover, ultrasound-guided biopsies are less invasive and generally quicker than other methods, requiring only local anesthesia. This further improves patient comfort and reduces recovery time. Compared to other imaging modalities like MRI or CT scans, ultrasound is considerably less expensive and more widely available across healthcare settings, including smaller clinics and outpatient centers. This accessibility makes it a go-to option for many physicians. Besides this, ultrasound does not involve exposure to ionizing radiation, making it a safer alternative for repeated procedures and specific patient populations, such as pregnant women. Due to these advantages-real-time imaging, cost-effectiveness, minimal invasiveness, and safety-ultrasound-guided biopsy is widely preferred, contributing to segment growth.

Breakup by End User:

Hospitals and Clinics
Academic and Research Institutes
Others

Hospitals and clinics are often the first point of contact for patients requiring diagnostic procedures, including biopsies. These healthcare settings are equipped with advanced diagnostic tools and skilled professionals capable of performing a wide range of biopsy types. The growing incidence of diseases requiring biopsies, coupled with the expansion of healthcare infrastructure globally, has led to higher adoption of biopsy devices in these institutions. Moreover, hospitals often have the financial capacity to invest in the latest biopsy technologies, further augmenting the market growth.

Although smaller in market share compared to hospitals and clinics, academic and research institutes are an essential segment. These institutions primarily focus on research and development activities aimed at improving biopsy technologies or devising new diagnostic methods. They may also conduct clinical trials to evaluate the efficacy of new biopsy devices. While the volume of biopsies performed may be lower compared to hospitals, their influence on product innovation and validation is significant.

Breakup by Region:

North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

North America exhibits a clear dominance in the market

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share since the region has a high prevalence of lifestyle-related diseases, including cancer, necessitating frequent utilization of biopsy procedures for diagnosis and monitoring. According to the American Cancer Society, in 2021, an estimated 1.9 million new cancer cases were diagnosed in the United States alone. In addition, North America boasts a highly developed healthcare infrastructure, including hospitals and clinics equipped with advanced diagnostic technologies, thereby facilitating the adoption of state-of-the-art biopsy devices.

Apart from this, the region has significant investments in healthcare research and development, often leading the way in medical innovation, including the development of new and more effective biopsy techniques and devices. Furthermore, there is a strong insurance framework supporting medical procedures, including biopsies, which makes these diagnostic tests more accessible to a broader population. Also, high levels of public awareness about the importance of early diagnosis and preventive healthcare catalyze the demand for diagnostic procedures such as biopsies. These combined factors position North America as the leading regional market for biopsy devices.

Competitive Landscape:

The market is experiencing steady growth as key players are actively engaged in a range of strategic activities aimed at consolidating their market position. These actions include the development of technologically advanced devices, such as vacuum-assisted and image-guided biopsy systems, to increase accuracy and patient comfort. Companies are also focusing on mergers, acquisitions, and strategic collaborations to expand their product portfolios and geographic reach. Additionally, significant investment is being made in research and development (R&D) to innovate new products and improve existing ones. Regulatory approvals and patent filings are other critical areas of focus aimed at securing exclusivity for innovative devices. Through these combined efforts, key market players are shaping the trajectory of the biopsy devices industry.

The market research report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Argon Medical Devices
Becton Dickinson and Company
Boston Scientific Corporation
Cardinal Health Inc.
CONMED Corporation
Cook Group Incorporated
Hologic Inc.
INRAD Inc.
Medtronic plc

Key Questions Answered in This Report:

How has the global biopsy devices market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global biopsy devices market?
What is the impact of each driver, restraint, and opportunity on the global biopsy devices market?
What are the key regional markets?
Which countries represent the most attractive biopsy devices market?
What is the breakup of the market based on the procedure type?
Which is the most attractive procedure type in the biopsy devices market?
What is the breakup of the market based on the product?
Which is the most attractive product in the biopsy devices market?
What is the breakup of the market based on the application?
Which is the most attractive application in the biopsy devices market?
What is the breakup of the market based on the guidance technique?
Which is the most attractive guidance technique in the biopsy devices market?
What is the breakup of the market based on the end-user?
Which is the most attractive end-user in the biopsy devices market?
What is the competitive structure of the global biopsy devices market?
Who are the key players/companies in the global biopsy devices market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Biopsy Devices Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID 19
5.4 Market Forecast

6 Market Breakup by Procedure Type

6.1 Surgical Biopsy
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Needle Biopsy
- 6.2.1 Market Trends
- 6.2.2 Market Forecast

7 Market Breakup by Product

7.1 Biopsy Guidance Systems
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Needle Based Biopsy Guns
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Biopsy Needles
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Biopsy Forceps
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast

8 Market Breakup by Application

8.1 Breast Biopsy
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Lung Biopsy
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Colorectal Biopsy
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Prostate Biopsy
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast

9 Market Breakup by Guidance Technique

9.1 Ultrasound-guided Biopsy
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Stereotactic-guided Biopsy
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 MRI-guided Biopsy
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast

10 Market Breakup by End-User

10.1 Hospitals and Clinics
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
10.2 Academic and Research Institutes
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
10.3 Others
- 10.3.1 Market Trends
- 10.3.2 Market Forecast

11 Market Breakup by Region

11.1 North America
- 11.1.1 United States
  - 11.1.1.1 Market Trends
  - 11.1.1.2 Market Forecast
- 11.1.2 Canada
  - 11.1.2.1 Market Trends
  - 11.1.2.2 Market Forecast
11.2 Asia Pacific
- 11.2.1 China
  - 11.2.1.1 Market Trends
  - 11.2.1.2 Market Forecast
- 11.2.2 Japan
  - 11.2.2.1 Market Trends
  - 11.2.2.2 Market Forecast
- 11.2.3 India
  - 11.2.3.1 Market Trends
  - 11.2.3.2 Market Forecast
- 11.2.4 South Korea
  - 11.2.4.1 Market Trends
  - 11.2.4.2 Market Forecast
- 11.2.5 Australia
  - 11.2.5.1 Market Trends
  - 11.2.5.2 Market Forecast
- 11.2.6 Indonesia
  - 11.2.6.1 Market Trends
  - 11.2.6.2 Market Forecast
- 11.2.7 Others
  - 11.2.7.1 Market Trends
  - 11.2.7.2 Market Forecast
11.3 Europe
- 11.3.1 Germany
  - 11.3.1.1 Market Trends
  - 11.3.1.2 Market Forecast
- 11.3.2 France
  - 11.3.2.1 Market Trends
  - 11.3.2.2 Market Forecast
- 11.3.3 United Kingdom
  - 11.3.3.1 Market Trends
  - 11.3.3.2 Market Forecast
- 11.3.4 Italy
  - 11.3.4.1 Market Trends
  - 11.3.4.2 Market Forecast
- 11.3.5 Spain
  - 11.3.5.1 Market Trends
  - 11.3.5.2 Market Forecast
- 11.3.6 Russia
  - 11.3.6.1 Market Trends
  - 11.3.6.2 Market Forecast
- 11.3.7 Others
  - 11.3.7.1 Market Trends
  - 11.3.7.2 Market Forecast
11.4 Latin America
- 11.4.1 Brazil
  - 11.4.1.1 Market Trends
  - 11.4.1.2 Market Forecast
- 11.4.2 Mexico
  - 11.4.2.1 Market Trends
  - 11.4.2.2 Market Forecast
- 11.4.3 Others
  - 11.4.3.1 Market Trends
  - 11.4.3.2 Market Forecast
11.5 Middle East and Africa
- 11.5.1 Market Trends
- 11.5.2 Market Breakup by Country
- 11.5.3 Market Forecast

12 SWOT Analysis

12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes

15 Price Indicators

16 Competitive Landscape

16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
- 16.3.1 Argon Medical Devices
  - 16.3.1.1 Company Overview
  - 16.3.1.2 Product Portfolio
- 16.3.2 Becton Dickinson and Company
  - 16.3.2.1 Company Overview
  - 16.3.2.2 Product Portfolio
  - 16.3.2.3 Financials
  - 16.3.2.4 SWOT Analysis
- 16.3.3 Boston Scientific Corporation
  - 16.3.3.1 Company Overview
  - 16.3.3.2 Product Portfolio
  - 16.3.3.3 Financials
  - 16.3.3.4 SWOT Analysis
- 16.3.4 Cardinal Health Inc.
  - 16.3.4.1 Company Overview
  - 16.3.4.2 Product Portfolio
  - 16.3.4.3 Financials
  - 16.3.4.4 SWOT Analysis
- 16.3.5 CONMED Corporation
  - 16.3.5.1 Company Overview
  - 16.3.5.2 Product Portfolio
- 16.3.6 Cook Group Incorporated
  - 16.3.6.1 Company Overview
  - 16.3.6.2 Product Portfolio
- 16.3.7 Hologic Inc.
  - 16.3.7.1 Company Overview
  - 16.3.7.2 Product Portfolio
  - 16.3.7.3 Financials
  - 16.3.7.4 SWOT Analysis
- 16.3.8 INRAD Inc.
  - 16.3.8.1 Company Overview
  - 16.3.8.2 Product Portfolio
- 16.3.9 Medtronic plc
  - 16.3.9.1 Company Overview
  - 16.3.9.2 Product Portfolio
  - 16.3.9.3 SWOT Analysis

生検装置市場レポート：手技タイプ、製品、用途、ガイダンス技術、エンドユーザー、地域別、2025年～2033年

Biopsy Devices Market Report by Procedure Type, Product, Application, Guidance Technique, End User, and Region 2025-2033

生検装置市場動向/促進要因：

目次

第1章 序文

第2章 調査範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界の生検装置市場

第6章 市場内訳：手技タイプ別

第7章 市場内訳：製品別

第8章 市場内訳：用途別

第9章 市場内訳：ガイダンステクニック

第10章 市場内訳：エンドユーザー別

第11章 市場内訳：地域別

第12章 SWOT分析

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

第15章 価格指標

第16章 競合情勢